ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 16.75 CNY | +3.97% |
|
+6.62% | +14.18% |
| Apr. 29 | Zhejiang Huahai Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Apr. 24 | Huahai Pharmaceutical Gets Approval to Market Busulfan Injection | MT |
Evolution of the average Target Price on Zhejiang Huahai Pharmaceutical Co., Ltd.
Price target over the last 5 years
History of analyst recommendation changes
e95b865c42a1487c17a8fe5.FkayFuPLj97Gfp4QiuyumNMsRxpFOqt9gNBHft1z7z4.UTHRdduZx5ulMOpU05yY2eF2CVsQYM8-0OMNT7kq3GFXL9xBr5HFmZc5pg~407756c12d4b98f9199176f6bd20a5f6
Analysts' Consensus
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
16.75
CNY
Average target price
16.37
CNY
Spread / Average Target
-2.29%
High Price Target
19.5
CNY
Spread / Highest target
+16.42%
Low Price Target
14
CNY
Spread / Lowest Target
-16.42%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
C+
EPS Revisions
- Stock Market
- Equities
- 600521 Stock
- Consensus Zhejiang Huahai Pharmaceutical Co., Ltd.
